Our Mission
Our Funders
Our Leadership
Our Team
Resources
News and Update
Contact
Resources
Resources
2025 Annual Specialty Drug Survey Report: A Data-Driven Look at Specialty Drug Costs in 2024
Debra McCarron
·
Mar 20, 2026
Resources
Our Year in Review: The Institute’s 2025 Impact Report
Ariel Le
·
Feb 6, 2026
Resources
Public Sector Medicare Advantage EGWPs In a Shifting Landscape: Challenges, Opportunities, and Policy Considerations
healthinstit
·
Jun 24, 2025
Resources
The Relationship Between PBMs and Public Sector Health Care Purchasers: Insights from Plan Sponsors
healthinstit
·
Mar 11, 2025
Resources
2024 Assessing the Unsustainable Cost of Specialty Medications
healthinstit
·
Nov 13, 2024
Resources
The Value of Medicare Advantage Employer Group Waiver Plans in the Public Sector: An Introduction
Debra McCarron
·
May 9, 2024
Resources
Assessing the Unsustainable Cost of Specialty Medications
Debra McCarron
·
Feb 20, 2024
Resources
How Public Sector Health Care Purchasers are Addressing Rising Drug Costs
Debra McCarron
·
Dec 12, 2023
Search
Archive
March 2026
February 2026
January 2026
June 2025
March 2025
November 2024
May 2024
February 2024
January 2024
December 2023
June 2023
Categories
Announcements
Resources
Recent Posts
2025 Annual Specialty Drug Survey Report: A Data-Driven Look at Specialty Drug Costs in 2024
March 20, 2026
National Institute for Public Employee Health Care Policy Submits Testimony
February 23, 2026
Our Year in Review: The Institute’s 2025 Impact Report
February 6, 2026
Marta Green, Executive Director Speaks at 37th Annual Pension & Benefits Seminar hosted by the National Association of Police Organizations.
January 30, 2026
Public Sector Medicare Advantage EGWPs In a Shifting Landscape: Challenges, Opportunities, and Policy Considerations
June 24, 2025
Tags
News
Social Links
Facebook
Twitter
LinkedIn
Instagram